Skip to main content
UK - Financial Adviser
Select Region Select User Type
  • Global
    • Home
  • UK Investors
    • Financial Adviser
    • Private Investor
  • International Investors
    • Private Investor
    • Professional Investor
  • Fund Centre
    • Our Funds
      • Equities
        • Rathbone Global Opportunities Fund
        • Rathbone Greenbank Global Sustainability Fund
        • Rathbone Income Fund Fund
        • Rathbone UK Opportunities Fund
      • Fixed Income
        • Rathbone Ethical bond Fund
        • Rathbone High Quality Bond Fund
        • Rathbone Strategic Bond Fund
        • Rathbone Greenbank Global Sustainable Bond Fund
      • Multi-Asset
        • Rathbone Greenbank Multi-Asset Portfolios
        • Rathbone MULTI-ASSET PORTFOLIOS
      • Sustainable
        • Rathbone Greenbank Global Sustainable Bond Fund
        • Rathbone Greenbank Global Sustainability Fund
        • Rathbone Greenbank Multi-Asset Portfolios
    • Literature Library
    • Consumer Duty
    • Prices and Performance
    • Glossary of Terms and FAQs
  • Strategies
    • Equities
    • Fixed Income
    • Multi-Asset
    • Sustainable
  • Our Clients
    • Private Investor
    • Financial Adviser
    • International Private Investor
    • International Financial Adviser
  • Rathbones
  • Global Home
  • Insights
    • Fund Insights
    • In the know blog
    • Review of the week
    • The Sharpe End podcast
  • About us
    • About us
    • Our People
    • Awards
    • Media centre
    • Responsible Investing at Rathbones
  • Contact
Home Home

Search

  • Fund Centre
    • Our Funds
      • Equities
        • Rathbone Global Opportunities Fund
        • Rathbone Greenbank Global Sustainability Fund
        • Rathbone Income Fund Fund
        • Rathbone UK Opportunities Fund
      • Fixed Income
        • Rathbone Ethical bond Fund
        • Rathbone High Quality Bond Fund
        • Rathbone Strategic Bond Fund
        • Rathbone Greenbank Global Sustainable Bond Fund
      • Multi-Asset
        • Rathbone Greenbank Multi-Asset Portfolios
        • Rathbone MULTI-ASSET PORTFOLIOS
      • Sustainable
        • Rathbone Greenbank Global Sustainable Bond Fund
        • Rathbone Greenbank Global Sustainability Fund
        • Rathbone Greenbank Multi-Asset Portfolios
    • Literature Library
    • Consumer Duty
    • Prices and Performance
    • Glossary of Terms and FAQs
  • Strategies
    • Equities
    • Fixed Income
    • Multi-Asset
    • Sustainable
  • Our Clients
    • Private Investor
    • Financial Adviser
    • International Private Investor
    • International Financial Adviser
  • Rathbones
  • Global Home
  • Insights
    • Fund Insights
    • In the know blog
    • Review of the week
    • The Sharpe End podcast
  • About us
    • About us
    • Our People
    • Awards
    • Media centre
    • Responsible Investing at Rathbones
  • Contact
Home

Search

A big fat magic marker

Confusion reigns because of the sheer amount of information flying around us. Yet all that activity should bring us comfort as it's helping fight the pandemic and its economic effects, argues head of fixed income Bryn Jones.

19 June 2020

Do you remember that scene in Pulp Fiction where Uma Thurman is brought back from the brink with an adrenaline shot? Once, my son had a similar – more G-rated! – type of medical miracle.

When he was younger, asthma and croup used to give him the worst coughs. I’ll never forget one night when we had to call the ambulance and he was given a shot of dexamethasone. This anti-inflammatory drug stopped his coughing instantly. Apart from Pulp Fiction, I have never seen anything like it.

This is the drug being trialled at Oxford University which has been shown to dramatically improve survival rates for those admitted to hospital. I certainly reckon they might be onto something here: it’s one powerful drug. It could help the world’s health systems deal with a second wave of the virus without crippling society once again. Another exciting breakthrough has come from my old uni: the Institute of Immunology and Immunotherapy at Birmingham has developed an antibody test that it claims is simpler and more accurate than current tests because it searches for a different viral marker in the blood. Such a test would make determining who has already had the virus (and therefore likely has immunity) much quicker and help the world get back to some semblance of normality.

Promising developments like these help drive optimism and push stock and bond markets higher. Yet there is never a silver bullet for fixing something as complex as what we’re living through. China has had an iron-clad testing, tracing and quarantining regime for virtually all of 2020, yet even it is experiencing new outbreaks. The world is in such a tangle of different stages of the pandemic. China is closing schools and shutting down parts of Beijing two months after ending its lockdown of epicentre Wuhan. Roughly 15,000-30,000 new cases are reported each day in the US even as it comes out of lockdown. Parisian cafes and restaurants have already reopened with limited social distancing even as just a few hundred miles north, across the Channel, we’re still a month at least from enjoying a bite out. Yet I hear my kids are going back to school on Monday. Meanwhile, the developing world is still in the midst of strict lockdowns as the virus spreads rapidly. Globally, the pandemic is still growing; this week we posted a grim new record of 142,000 new cases in a single day.

This confusing global picture, allied with simultaneously released really good and really terrible economic numbers, will continue to sow confusion among people and markets. The battle between optimism and pessimism is creating see-saw movements in both shares and bonds that aren’t going anywhere soon. Faced with this picture, central banks are taking no chances. They have already fired off a stupendous amount of support for markets and businesses, from cutting interest rates to nigh on zero and extending sweetheart loans to companies, to buying billions of pounds’ worth of bonds to keep borrowing rates low for governments and businesses.

Just this week the Bank of England added another £100 billion to its quantitative easing (QE) programme. Yet at the same time the bank cut the amount of bonds it buys each week under QE from £13.5 billion to £4.5 billion. To put these massive figures into context, buying £13.5 billion each week for a year would equate to about 25% of the country’s GDP, while £4.5 billion weekly would amount to just 8%. This week the US Federal Reserve is finally buying corporate bonds directly after a spell of purchasing them through ETFs. Brazil’s central bank has slashed its interest rate by another 0.75%, taking it to a record low of 2.25%, while Chile has announced $8billion of QE.

The sheer weight of information and narrative and stats thrown around at the moment can be overwhelming. Yet after I take a moment it actually gives me some comfort. There’s so much going on, so many unprecedented responses to the dangers we face, that it’s hard to stay on top of it all. It’s hard to keep track of all the ways we as a global society are trying to fight this virus together. This is good medicine that brings real comfort.

 

 

Let's Talk

Ready to start a conversation? Please complete our enquiry form, we look forward to speaking with you

Enquire
  • Important Information
    • Brexit Statement
    • Important information
    • UK Modern Slavery Act
    • Accessibility
    • Privacy
    • Cookies
    • Cookie preferences
    • Complaints
  • Important Information
    • Consumer Duty
    • Voting disclosure
    • Assessment of value reports
    • TCFD Reports
    • SDR Consumer-Facing Disclosures
    • Financial Ombudsman Service
    • Financial Services Compensation Scheme
    • Glossary of terms and FAQs
    • MIFIDPRU8
Address

Rathbones Asset Management
30 Gresham Street
London
EC2V 7QN

Rathbones Asset Management Limited is authorised and regulated by the Financial Conduct Authority and a member of the Investment Association. A member of the Rathbone Group. Registered Office 30 Gresham Street, London EC2V 7QN. Registered in England No 02376568.

© 2025 Rathbones Group Plc
Incorporated and registered in England and Wales. Registered number 01000403

Follow us
LinkedIn
City Hive Logo
ACT Logo

Rathbones Asset Management is delighted to be an early signatory of the ACT Framework created by City Hive

Diversity Project Logo

Rathbones Asset Management is a member of The Diversity Project

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.